Drug intelligence / Profile preview

Heal Quick

Development stage
Phase 1
Lead developer
Al Hadidi Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Heal Quick is a topical pharmaceutical cream containing 2% phenytoin, produced by Al Hadidi Pharm. Although phenytoin is traditionally known as a systemic anticonvulsant, Heal Quick is specifically formulated for wound management. The therapeutic effect of topical phenytoin is attributed to its ability to stimulate fibroblast proliferation, increase the formation of granulation tissue, and decrease collagenase activity, which collectively accelerate the process of epithelialization and angiogenesis. It is primarily used to promote healing in post-operative wounds, such as those following anal sphincterotomy, as well as in chronic conditions like diabetic foot ulcers and pressure sores. The formulation allows for localized regenerative action with minimal systemic absorption.

Brand names
Heal Quick
Other names
phenytoin 2% cream
02

Targets

SCN5A (Sodium channel protein type 5 subunit alpha)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)SCN3A (Sodium channel protein type 3 subunit alpha)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)

Beyond the preview

Go deeper on Heal Quick.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heal Quick.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call